Acteev™ technology
Print this page

Acteev™ technology

DISCLAIMER: Acteev™ technology has been shown in laboratory tests to destroy SARS-CoV-2, the coronavirus that causes COVID-19, and other pathogens including H1N1, coronavirus 229E and Gram-positive and Gram-negative bacteria such as staphylococcus and E. coli. All data presented on this page comes from testing performed by independent third-party laboratories following the protocols of ISO, ASTM or other international standards organizations. Not all claims are permitted in all jurisdictions, including in the United States. Some device designs currently under review with the U.S. Food and Drug Administration — submission number K201714. Ascend has more than 15 patent families pending on Acteev technology.

Introducing Acteev technology

  • Tests show antiviral, antibacterial, antifungal efficacy

  • EPA-registered active ingredient embedded in the polymer

  • Hygroscopic nylon 6,6 fabric absorbs moisture droplets to activate the zinc ions

  • Not a topical treatment or coating

  • Not dependent on silver, copper

  • Proven efficacy in many end forms:
    • Knit and woven fabrics for consumer textiles, upholstery, uniforms, face masks
    • Nanofiber, meltblown and spunbond nonwovens for filtration
    • Fibers for carpets
    • Engineered plastics for high-touch surfaces

How Acteev works

Acteev technology combines virus-deactivating active zinc ions with the softness of polyamide fabrics and fibers to deliver unparalleled performance and antimicrobial efficacy. Acteev's patent-pending technology embeds active zinc ions into the matrix of the polymer. Unlike topical finishes or coatings, the zinc ions don't flake away, providing long-lasting functionality.

Efficacy results

Ascend has partnered with world-renowned scientists and laboratories to analyze this cutting-edge technology. 

Microbe Efficacy Test standard
SARS-CoV-2, the cause of COVID-19 99% in 60 minutes ISO 18184 / ASTM E2197
Human coronavirus 229E 99.9% in 120 minutes ISO 18184 / ASTM E2197
H1N1 90% instantly ISO 18184 / ASTM E2197
Staphylococcus aureus 99.999% ISO 20743
Klebsiella pneumoniae 99.999% ISO 20743
E. coli 99.999% ASTM E3160
Aspergillus brasiliensis, Penicillium funiculosum, Chaetomium globosum, Trichoderma virens, Aureobasidium pullulans No growth ASTM G21

Acteev product lines

In development since 2016, Acteev technology was created by Ascend's team of nearly 200 R&D scientists and engineers. Now, with more than 15 patent families pending, Ascend has launched Acteev Protect™ for sale and is ready to sample Acteev Biodefend™.

Contact an Ascend expert to request a sample or learn more about our technology